Difference between revisions of "Team:Uppsala"

Line 126: Line 126:
 
<img src="https://static.igem.org/mediawiki/2017/4/4a/Test_crtIEBZY_2.jpg" style="display: block; margin: auto; width:40%; height: auto; padding-bottom:3%">
 
<img src="https://static.igem.org/mediawiki/2017/4/4a/Test_crtIEBZY_2.jpg" style="display: block; margin: auto; width:40%; height: auto; padding-bottom:3%">
 
<br><br>
 
<br><br>
The crocin pathway is very poorly characterized. In addition to this its compounds are very expensive due to the labour-intensive harvest of saffron. Our <a href="https://static.igem.org/mediawiki/2017/d/d8/Uppsala-Market-analysis.pdf" target="_blank">market analysis</a> show that saffron and its components has a promising increase in market value. By using synthetic biology for recombinant expression in <i>Escherichia Coli</i> we hope to reduce the price of the compounds within the crocin pathway and open up the possibility for industrial and medicinal applications to be further explored. To develop our project further, we have done extensive <a href="https://2017.igem.org/Team:Uppsala/Model">homology modeling, molecular dynamics and kinetic measurements</a> to characterize the enzymes in our pathway. When working with recombinant microorganisms, and as well when introducing a new manufacturing method to the saffron market, we realized it was very important for us to take <a href="https://2017.igem.org/Team:Uppsala/HP/Gold_Integrated">ethical aspects</a> into account. To understand the ethical concerns further we spoke to experts, collaborated with other iGEM teams and organized events for the public.</div>
+
The crocin pathway is very poorly characterized and its compounds are very expensive due to the labour-intensive harvest of saffron. We made a <a href="https://static.igem.org/mediawiki/2017/d/d8/Uppsala-Market-analysis.pdf" target="_blank">market analysis</a> and we believe that by using synthetic biology for recombinant expression in <i>Escherichia Coli</i> we could reduce the price of the compounds within the crocin pathway and open up the possibility for industrial and medicinal applications to be further explored. To develop our project further, we have done extensive <a href="https://2017.igem.org/Team:Uppsala/Model">homology modeling, molecular dynamics and kinetic measurements</a> to characterize the enzymes in our pathway. When working with recombinant microorganisms, and as well when introducing a new manufacturing method to the saffron market, we realized it was very important for us to take <a href="https://2017.igem.org/Team:Uppsala/HP/Gold_Integrated">ethical aspects</a> into account. To understand the ethical concerns further we spoke to experts, collaborated with other iGEM teams and organized events for the public.</div>
  
 
<div class="somethingsomething"> Our achievements this year are:</div>
 
<div class="somethingsomething"> Our achievements this year are:</div>

Revision as of 15:45, 1 November 2017

Crafting Crocin